What is the 13F Pro Quality Score for SONM?

13F Pro ranks DNA X, Inc. (SONM) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SONM's current score at https://13fpro.ai/research/SONM (free sign-up required for the full ranking).

Which hedge funds own the most SONM stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of SONM include UBS Group AG, C2C Wealth Management,, GEODE CAPITAL MANAGEMENT,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/SONM as soon as new 13F filings post.

Where does 13F Pro source SONM data?

All DNA X, Inc. fundamentals and ownership data come directly from SEC EDGAR. DNA X, Inc. files with the SEC under CIK 1178697. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SONM in?

DNA X, Inc. (SONM) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

How often is SONM research updated on 13F Pro?

SONM's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

DNA X, Inc.(SONM)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1178697 SONM stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 9 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

SONM Stock Analysis & AI Quality Score

AI stock analysis and institutional research for DNA X, Inc. (SONM), a Technology sector company. SONM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 9 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q1 2026), DNA X, Inc. reports net income of $6.3M, free cash flow of $-3.5M. Top institutional holders of SONM by reported 13-F value include UBS Group AG, C2C Wealth Management,, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. SONM trades on the Nasdaq exchange and files with the SEC under CIK 1178697. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SONM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DNA X, Inc. directly from SEC EDGAR.

Net Income

Q1 2026

$6.3M

Free Cash Flow

Q1 2026

$-3.5M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+34.1% YoY

$93.6MFY 2023

FY19 $116.3MFY21 $54.6MFY22 $69.8MFY23 $93.6M

Net Income

+99.4% YoY

$-90.0KFY 2023

FY19 $-25.8MFY21 $-38.6MFY22 $-14.1MFY23 $-90.0K

Operating Income

+103.6% YoY

$513.0KFY 2023

FY19 $-22.4MFY21 $-38.0MFY22 $-14.3MFY23 $513.0K

EPS (Diluted)

+95.9% YoY

$-0.02FY 2023

FY19 —FY21 —FY22 $-0.49FY23 $-0.02

Total Assets

+4.4% YoY

$56.0MFY 2023

FY19 $55.5MFY21 $41.1MFY22 $53.7MFY23 $56.0M

Total Debt

—FY 2023

FY19 $20.0MFY21 $214.0KFY22 $147.0KFY23 —

Op. Cash Flow

+67.2% YoY

$-4.1MFY 2023

FY19 $-33.5MFY21 $-38.5MFY22 $-12.4MFY23 $-4.1M

Metric	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018
Revenue	$93.6M +34.1%	$69.8M +28.0%	$54.6M -53.1%	$116.3M -14.3%	$135.7M
Net Income	$-90.0K +99.4%	$-14.1M +63.5%	$-38.6M -49.5%	$-25.8M -2123.0%	$1.3M
Operating Income	$513.0K +103.6%	$-14.3M +62.4%	$-38.0M -69.8%	$-22.4M -514.9%	$5.4M
EPS (Diluted)	$-0.02 +95.9%	$-0.49	—	—	—
Total Assets	$56.0M +4.4%	$53.7M +30.7%	$41.1M -25.9%	$55.5M -17.6%	$67.3M
Total Debt	—	$147.0K -31.3%	$214.0K -98.9%	$20.0M +44.8%	$13.8M
Operating Cash Flow	$-4.1M +67.2%	$-12.4M +67.9%	$-38.5M -14.8%	$-33.5M -968.2%	$3.9M

AI Insight: SONM Financial Trends

DNA X swung to net profitability in Q1 2026 despite persistent operating losses and negative cash flow, while debt remains elevated at $2M.

• Net income turned positive at $6M in Q1 2026, first profitable quarter since Q1 2025's breakeven result.

• Operating cash flow remained deeply negative across all eight quarters, ranging from -$10M to -$0M; no improvement trend visible.

• Total debt rose from $0M in Q3 2024 to $10M by Q3 2025, though declined to $2M in latest quarter.

⚠ Equity deteriorated sharply from $17M in Q2 2024 to -$8M in Q4 2025, though recovered slightly to -$1M in Q1 2026.

⚠ Revenue data missing for Q4 2025 and Q1 2026; cannot assess top-line trajectory or profitability sustainability.

⚠ Operating income turned positive $5M in Q4 2025 but reversed to -$4M in Q1 2026 despite net income swing to +$6M.

AI Insight: SONM Ratio Trends

DNA X remains deeply unprofitable with volatile margins; Q1 2025's brief profitability inflection failed to sustain.

• Operating margin swung from -60.2% in Q2 2025 to -24.6% in Q3 2025, showing reduced loss severity but persistent unprofitability.

• ROA deteriorated sharply: -5.1% in Q1 2025 improved briefly, then collapsed to -47.3% in Q3 2025 and -81.0% in Q4 2025.

• Q1 2025 marked only profitable quarter on record (OpMargin +3.9%, NPM +2.7%) before reverting to losses.

⚠ Q4 2025 ROA of -81.0% signals severe asset base deterioration or massive loss in final quarter; TTM data unavailable.

⚠ No leverage data (D/E) reported; capital structure health opaque during consistent unprofitable operations.

Get alerted when SONM's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DNA X, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SONM

UBS Group AG
$146.0K36,219 sh
C2C Wealth Management, LLC
$80.6K20,000 sh
GEODE CAPITAL MANAGEMENT, LLC
$59.7K14,802 sh
BlackRock, Inc.
$56.4K14,006 sh
VANGUARD CAPITAL MANAGEMENT LLC
$19.7K4,892 sh
VANGUARD FIDUCIARY TRUST CO
$18.1K4,496 sh
Tower Research Capital LLC (TRC)
$2.7K661 sh
SBI Securities Co., Ltd.
$862.00214 sh
DANSKE BANK A/S
$16.004 sh

Fund	Value	Shares
UBS Group AG	$146.0K	36,219
C2C Wealth Management, LLC	$80.6K	20,000
GEODE CAPITAL MANAGEMENT, LLC	$59.7K	14,802
BlackRock, Inc.	$56.4K	14,006
VANGUARD CAPITAL MANAGEMENT LLC	$19.7K	4,892
VANGUARD FIDUCIARY TRUST CO	$18.1K	4,496
Tower Research Capital LLC (TRC)	$2.7K	661
SBI Securities Co., Ltd.	$862.00	214
DANSKE BANK A/S	$16.00	4

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put SONM on your watchlist

Track score changes the day DNA X, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SONM a good stock to buy?

13F Pro's AI-powered analysis of DNA X, Inc. (SONM) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SONM are available on the SONM stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own SONM?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SONM. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DNA X, Inc.'s investment landscape.